• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自结肠癌低发地区的溃疡性结肠炎相关性结直肠癌

Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.

作者信息

Desai Devendra, Shah Sudeep, Deshmukh Abhijit, Abraham Philip, Joshi Anand, Gupta Tarun, Deshpande Ramesh, Khandagale Varun, George Siji

机构信息

Devendra Desai, Abhijit Deshmukh, Philip Abraham, Anand Joshi, Tarun Gupta, Varun Khandagale, Siji George, Division of Gastroenterology, P.D Hinduja Hospital, Mumbai 400016, India.

出版信息

World J Gastroenterol. 2015 Mar 28;21(12):3644-9. doi: 10.3748/wjg.v21.i12.3644.

DOI:10.3748/wjg.v21.i12.3644
PMID:25834332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4375589/
Abstract

AIM

To determine the incidence and risk factors for colorectal cancer (CRC) in patients with ulcerative colitis from a low prevalence region for CRC.

METHODS

Our prospective database yielded a cohort of 430 patients [age: 44 ± 14.6 years; 248 men (57.7%)] with ulcerative colitis (median disease duration 6, range: 1-39 years) for analysis. Of these, 131 (30.5%) had left-sided colitis and 159 (37%) extensive colitis. Patients with histologically confirmed CRC within the segment with colitis were compared with those without CRC, to determine the risk factors for the development of CRC.

RESULTS

Twelve patients (2.8%) developed CRC. The overall incidence density was 3.56/1000 patient-years of disease - 3/1000 in the first 10 years, 3.3/1000 at 10 to 20 years, and 7/1000 at > 20 years. Three of our 12 patients developed CRC within 8 years of disease onset. On univariate analysis, extensive colitis, longer duration of disease, and poor control of disease were associated with development of CRC. On multivariate analysis, duration of disease and extent of colitis remained significant.

CONCLUSION

CRC occurred in 2.8% of patients with ulcerative colitis in our population - an incidence density similar to that in Western countries in spite of a low overall prevalence of colon cancer in our population. The risk increased with extent and duration of disease.

摘要

目的

确定来自结直肠癌低发地区的溃疡性结肠炎患者结直肠癌(CRC)的发病率及危险因素。

方法

我们的前瞻性数据库纳入了430例溃疡性结肠炎患者[年龄:44±14.6岁;男性248例(57.7%)]进行分析,其溃疡性结肠炎中位病程为6年(范围:1 - 39年)。其中,131例(30.5%)为左侧结肠炎,159例(37%)为广泛性结肠炎。将结肠炎节段内组织学确诊为CRC的患者与未患CRC的患者进行比较,以确定CRC发生的危险因素。

结果

12例患者(2.8%)发生CRC。总体发病密度为3.56/1000患者 - 年病程——发病首10年为3/1000,10至20年为3.3/1000,超过20年为7/1000。12例患者中有3例在发病8年内发生CRC。单因素分析显示,广泛性结肠炎、病程较长及病情控制不佳与CRC发生相关。多因素分析显示,病程及结肠炎范围仍具有显著意义。

结论

在我们的研究人群中,2.8%的溃疡性结肠炎患者发生了CRC——尽管我们人群中结肠癌总体患病率较低,但其发病密度与西方国家相似。发病风险随病情范围及病程增加而升高。

相似文献

1
Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.来自结肠癌低发地区的溃疡性结肠炎相关性结直肠癌
World J Gastroenterol. 2015 Mar 28;21(12):3644-9. doi: 10.3748/wjg.v21.i12.3644.
2
[Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].[匈牙利溃疡性结肠炎患者队列中溃疡性结肠炎相关结直肠癌的危险因素]
Orv Hetil. 2006 Jan 29;147(4):175-81.
3
Risk of colorectal cancer in ulcerative colitis in India.印度溃疡性结肠炎患者患结直肠癌的风险。
J Gastroenterol Hepatol. 2005 May;20(5):705-9. doi: 10.1111/j.1440-1746.2005.03810.x.
4
Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.炎症性肠病患者队列中临床参数与结直肠癌-结肠炎间隔时间的关系
Scand J Gastroenterol. 2009;44(1):46-55. doi: 10.1080/00365520801977568.
5
Epidemiology and risk factors for colorectal dysplasia and cancer in ulcerative colitis.溃疡性结肠炎患者结直肠发育异常及癌症的流行病学与危险因素
Gastroenterol Clin North Am. 2006 Sep;35(3):517-31. doi: 10.1016/j.gtc.2006.07.005.
6
Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.匈牙利溃疡性结肠炎患者队列中溃疡性结肠炎相关结直肠癌的危险因素:一项基于人群的研究结果
Inflamm Bowel Dis. 2006 Mar;12(3):205-11. doi: 10.1097/01.MIB.0000217770.21261.ce.
7
Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.溃疡性结肠炎患者结直肠癌的临床病理研究:来自日本一家医院的结果
Hepatogastroenterology. 2010 May-Jun;57(99-100):487-92.
8
Low incidence of colorectal dysplasia and cancer among patients with ulcerative colitis: a Turkish referral centre study.溃疡性结肠炎患者中结直肠发育异常和癌症的低发病率:一项土耳其转诊中心研究
Scand J Gastroenterol. 2010 Apr;45(4):434-9. doi: 10.3109/00365520903540830.
9
Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?溃疡性结肠炎患者的发育异常和结肠直肠癌在内镜检查中可见吗?
Gastrointest Endosc. 2007 Jun;65(7):998-1004. doi: 10.1016/j.gie.2006.09.025. Epub 2007 Apr 23.
10
Ulcerative colitis and colorectal cancer. A population-based study.溃疡性结肠炎与结直肠癌。一项基于人群的研究。
N Engl J Med. 1990 Nov 1;323(18):1228-33. doi: 10.1056/NEJM199011013231802.

引用本文的文献

1
Inflammatory bowel disease in south Asia: a scoping review.南亚的炎症性肠病:一项范围综述。
Lancet Gastroenterol Hepatol. 2025 Mar;10(3):259-274. doi: 10.1016/S2468-1253(24)00341-8.
2
Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.印度炎症性肠病患者原发性硬化性胆管炎的低患病率。
Intest Res. 2023 Oct;21(4):452-459. doi: 10.5217/ir.2022.00087. Epub 2022 Dec 2.
3
Inflammatory bowel disease in India: challenges and opportunities.印度的炎症性肠病:挑战与机遇
Frontline Gastroenterol. 2020 Jul 14;12(5):390-396. doi: 10.1136/flgastro-2020-101500. eCollection 2021.
4
Secondary colon cancer in patients with ulcerative colitis: a systematic review and meta-analysis.溃疡性结肠炎患者的继发性结肠癌:一项系统评价和荟萃分析
J Gastrointest Oncol. 2021 Dec;12(6):2882-2890. doi: 10.21037/jgo-21-800.
5
Correlation of ulcerative colitis and colorectal cancer: a systematic review and meta-analysis.溃疡性结肠炎与结直肠癌的相关性:一项系统评价与荟萃分析
J Gastrointest Oncol. 2021 Dec;12(6):2814-2822. doi: 10.21037/jgo-21-624.
6
Inflammatory bowel disease: An Indian perspective.炎症性肠病:印度视角。
Indian J Med Res. 2021 Apr;153(4):421-430. doi: 10.4103/ijmr.IJMR_936_18.
7
A study on the potential role of autophagy-related protein 10 as a biomarker for ulcerative colitis.自噬相关蛋白 10 作为溃疡性结肠炎生物标志物的潜力研究。
Physiol Rep. 2021 Apr;9(7):e14825. doi: 10.14814/phy2.14825.
8
Teasaponin Ameliorates Murine Colitis by Regulating Gut Microbiota and Suppressing the Immune System Response.茶皂素通过调节肠道微生物群和抑制免疫系统反应改善小鼠结肠炎。
Front Med (Lausanne). 2020 Dec 10;7:584369. doi: 10.3389/fmed.2020.584369. eCollection 2020.
9
The effect of intermittent hypoxia and fecal microbiota of OSAS on genes associated with colorectal cancer.间歇低氧和 OSAS 粪便微生物群对结直肠癌相关基因的影响。
Sleep Breath. 2021 Jun;25(2):1075-1087. doi: 10.1007/s11325-020-02204-z. Epub 2020 Oct 7.
10
Ulcerative colitis.溃疡性结肠炎。
Nat Rev Dis Primers. 2020 Sep 10;6(1):74. doi: 10.1038/s41572-020-0205-x.

本文引用的文献

1
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.炎症性肠病患者结直肠癌发病风险降低:基于人群队列研究的更新荟萃分析。
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):789-99. doi: 10.1097/MIB.0b013e31828029c0.
2
Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.美国老年患者结肠镜检查后早期/漏诊结直肠癌的发生率,无论是否患有炎症性肠病。
Am J Gastroenterol. 2013 Mar;108(3):444-9. doi: 10.1038/ajg.2012.429. Epub 2013 Jan 8.
3
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.欧洲关于溃疡性结肠炎诊断和管理的第二项循证共识,第3部分:特殊情况
J Crohns Colitis. 2013 Feb;7(1):1-33. doi: 10.1016/j.crohns.2012.09.005. Epub 2012 Oct 3.
4
Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.1998 年至 2010 年炎症性肠病患者结直肠腺癌的发病率和死亡率。
Gastroenterology. 2012 Aug;143(2):382-9. doi: 10.1053/j.gastro.2012.04.054. Epub 2012 May 15.
5
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.30 余年来炎症性肠病患者结直肠癌发病风险降低。
Gastroenterology. 2012 Aug;143(2):375-81.e1; quiz e13-4. doi: 10.1053/j.gastro.2012.04.016. Epub 2012 Apr 19.
6
Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.中国溃疡性结肠炎相关性结直肠癌的风险:一项多中心回顾性研究。
Dig Dis Sci. 2012 Feb;57(2):503-7. doi: 10.1007/s10620-011-1890-9. Epub 2011 Sep 22.
7
Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK.英国伦敦西北部的南亚人和北欧人之间炎症性肠病表型的差异。
Am J Gastroenterol. 2011 Jul;106(7):1281-9. doi: 10.1038/ajg.2011.85. Epub 2011 May 17.
8
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
9
Colorectal cancer in India: controversies, enigmas and primary prevention.印度的结直肠癌:争议、谜团与一级预防
Indian J Gastroenterol. 2011 Feb;30(1):3-6. doi: 10.1007/s12664-010-0076-2. Epub 2011 Jan 11.
10
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).结直肠癌筛查和监测指南(中高危人群)(2002 年更新)。
Gut. 2010 May;59(5):666-89. doi: 10.1136/gut.2009.179804.